导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.39% | 821/1050 |
| 近一周 | -2.19% | 743/1104 |
| 近一月 | -4.80% | 753/1103 |
| 近一季 | -19.10% | 957/1092 |
| 近半年 | -20.81% | 1009/1070 |
| 近一年 | 5.14% | 479/1018 |
| 近两年 | 68.35% | 386/926 |
| 近三年 | 37.14% | 349/834 |
| 成立以来 | 231.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
12.91% 23/1070 |
-0.53% 707/1101 |
- - |
- - |
| 2025 | 47.91% 211/1065 |
5.42% 384/1014 |
5.19% 288/1038 |
20.39% 597/1050 |
10.79% 40/1065 |
| 2024 | 0.05% 578/1011 |
-11.62% 818/960 |
-2.75% 487/983 |
13.88% 311/991 |
2.22% 228/1011 |
| 2023 | -12.12% 402/952 |
2.09% 505/880 |
-5.29% 545/895 |
-9.34% 560/915 |
0.26% 111/952 |
| 2022 | -19.19% 299/867 |
-19.37% 482/773 |
9.83% 277/806 |
-6.46% 95/845 |
-2.44% 556/867 |
| 2021 | 30.00% 71/740 |
1.62% 97/580 |
4.97% 469/659 |
12.03% 45/704 |
8.78% 105/740 |
| 2020 | 63.06% 175/554 |
-2.95% 235/419 |
29.33% 134/466 |
14.19% 159/517 |
13.78% 232/554 |
| 2019 | 40.24% 218/410 |
24.65% 727/1149 |
-8.40% 930/1231 |
6.40% 173/390 |
15.44% 46/410 |
| 2018 | -26.05% 164/349 |
- - |
- - |
- - |
-12.50% 656/1080 |
| 2017 | -9.16% 192/285 |
- - |
- - |
- - |
- - |
| 2016 | -5.27% 44/205 |
- - |
- - |
- - |
- - |
| 2015 | 44.53% 34/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华宝制造股票 VS. 东吴新产业精选股票A(580008) |